Abstract
Systemic lupus erythematosus is a multisystem disorder that presents itself in several different ways. Arthritis, dermatitis, nephritis, and pleuropericarditis are the most common features initially. Various hematologic and neuropsychiatric manifestations are also seen during the course of the disease. Anti-nuclear antibodies are the hallmark of lupus but are nonspecific and detectable in many other disorders. Once the diagnosis is established, the severity of the disease needs to be determined, in particular the extent of major organ involvement. The level of disease activity should be repeatedly estimated using clinical and laboratory parameters. Therapeutic decisions are based on disease severity and activity. Aggressive suppression of major organ inflammation and reduction of long-term toxicity are the main goals of therapy.
Keywords: family medicine, rheumatology, systemic lupus erythematosus
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fessel W. J. ANA-negative systemic lupus erythematosus. Am J Med. 1978 Jan;64(1):80–86. doi: 10.1016/0002-9343(78)90181-x. [DOI] [PubMed] [Google Scholar]
- Gladman D. D., Urowitz M. B., Keystone E. C. Serologically active clinically quiescent systemic lupus erythematosus: a discordance between clinical and serologic features. Am J Med. 1979 Feb;66(2):210–215. doi: 10.1016/0002-9343(79)90529-1. [DOI] [PubMed] [Google Scholar]
- Inoue T., Takeda T., Koda S., Negoro N., Okamura M., Amatsu K., Kohno M., Horiguchi T., Kanayama Y. Differential diagnosis of fever in systemic lupus erythematosus using discriminant analysis. Rheumatol Int. 1986;6(2):69–77. doi: 10.1007/BF00541508. [DOI] [PubMed] [Google Scholar]
- Kimberly R. P., Lockshin M. D., Sherman R. L., McDougal J. S., Inman R. D., Christian C. L. High-dose intravenous methylprednisolone pulse therapy in systemic lupus erythematosus. Am J Med. 1981 Apr;70(4):817–824. doi: 10.1016/0002-9343(81)90538-6. [DOI] [PubMed] [Google Scholar]
- Maddison P. J., Provost T. T., Reichlin M. Serological findings in patients with "ANA-negative" systemic lupus erythematosus. Medicine (Baltimore) 1981 Mar;60(2):87–94. doi: 10.1097/00005792-198103000-00002. [DOI] [PubMed] [Google Scholar]
- Parke A. L. Antiphospholipid antibody syndromes. Rheum Dis Clin North Am. 1989 May;15(2):275–286. [PubMed] [Google Scholar]
- Shiel W. C., Jr, Jason M. The diagnostic associations of patients with antinuclear antibodies referred to a community rheumatologist. J Rheumatol. 1989 Jun;16(6):782–785. [PubMed] [Google Scholar]
- Stahl N. I., Klippel J. H., Decker J. L. Fever in systemic lupus erythematosus. Am J Med. 1979 Dec;67(6):935–940. doi: 10.1016/0002-9343(79)90633-8. [DOI] [PubMed] [Google Scholar]
- Stevens M. B. Connective tissue disease in the elderly. Clin Rheum Dis. 1986 Apr;12(1):11–32. [PubMed] [Google Scholar]
- Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
- Tozman E. C., Urowitz M. B., Gladman D. D. Systemic lupus erythematosus and pregnancy. J Rheumatol. 1980 Sep-Oct;7(5):624–632. [PubMed] [Google Scholar]
- Urowitz M. B., Gladman D. D. Late mortality in SLE--"the price we pay for control". J Rheumatol. 1980 May-Jun;7(3):412–416. [PubMed] [Google Scholar]